GSK Bayer Pfizer
Emerging Healthcare Trends and Key Players from JPM25 Insights
NeelRatan
At the JPMorgan Healthcare Conference, significant developments emerged including GSK's billion-dollar investment, Bayer's groundbreaking trial, and Pfizer's strategy to address a $17 billion revenue loss. Additionally, the San Francisco Police Department confirmed full staffing for the event, marking a major industry gathering since the passing of UnitedHealthcare’s CEO.
